EndFA

EndFA is a non-profit organization and advocacy group dedicated to finding a cure for Friedreich's Ataxia (FA). The organization focuses on connecting the FA community, empowering patients, and accelerating research through strategic partnerships and funding. EndFA launched "The FA App," a mobile platform designed to unite patients, caregivers, and researchers while providing tools for clinical trial participation and disease management. Additionally, EndFA collaborates with leading institutions such as the Broad Institute and the University of Oxford to support drug discovery and translational research aimed at addressing the root cause of FA, which is frataxin deficiency.